长春中医药大学学报2024，Vol.40Issue(7)：722-724,3.DOI:10.13463/j.cnki.cczyy.2024.07.004
重构本草——辛夷
Reconstruction of Chinese materia medica-biond magnolia flower-bud
摘要
Abstract
Through in-depth investigation of ancient books and the systematic sorting of the modern research achievements of traditional Chinese medicine,combined with the understanding and application experience of experts in desciplinary fields such as traditional Chinese medicine clinical medicine and science of Chinese materia medica,it is concluded that biond magnolia flower-bud mainly has the effects of dispelling wind-cold,and relieving stuffy nose.The symptom targets are nasal obstruction and runny nose,and headache.Modern pharmacological studies have found that biond magnolia flower-bud and its active ingredients have anti-allergic,anti-inflammatory,anti-bacterial,and uterine stimulating effects.Biond magnolia flower-bud is non-poisonous,and when using this medicine,it should be decocted in wrapped condition.The main adverse reaction of biond magnolia flower-bud is gastrointestinal discomfort.Those with hyperactivity of fire due to yin deficiency should avoid taking it.This product can cause uterine contractions and is contraindicated for pregnant and postpartum women.The clinical dosage is 3-12 g.Due to the potential irritation of biond magnolia flower-bud to the gastrointestinal tract,patients should adopt a small dose gradual administration method when receiving this medicine for the first time.If the patient has no adverse reactions after receiving the small dose of medication,the drug dosage can be gradually adjusted according to the condition of the patient to ensure treatment effectiveness and medication safety.关键词
辛夷/症靶/重构本草/临床回归Key words
biond magnolia flower-bud/symptom target/reconstruction of Chinese materia medica/clinical verification分类
医药卫生引用本文复制引用
翟天纲,谢伟楠,赵锡艳..重构本草——辛夷[J].长春中医药大学学报,2024,40(7):722-724,3.基金项目
国家重点研发计划"中医药现代化"重点专项(2022YFC3502100) （2022YFC3502100）
国家自然科学基金(82205089) （82205089）
中央级公益性科研院所基本科研业务费专项资金(ZZ13-YQ-030) （ZZ13-YQ-030）
中国中医科学院科技创新工程重大攻关项目(CI2021A01614) （CI2021A01614）
中国中医科学院广安门医院临床医学研究中心建设专项经费(2022LYJSZX13) （2022LYJSZX13）
中央高水平中医医院临床研究和成果转化能力提升项目—传承名老中医药专家学术经验专项(HLCMHPP2023009) （HLCMHPP2023009）
